PE20010644A1 - Procesos para la produccion de acidos 2-fenilamino-5-alquilfenilaceticos - Google Patents

Procesos para la produccion de acidos 2-fenilamino-5-alquilfenilaceticos

Info

Publication number
PE20010644A1
PE20010644A1 PE2000001007A PE0010072000A PE20010644A1 PE 20010644 A1 PE20010644 A1 PE 20010644A1 PE 2000001007 A PE2000001007 A PE 2000001007A PE 0010072000 A PE0010072000 A PE 0010072000A PE 20010644 A1 PE20010644 A1 PE 20010644A1
Authority
PE
Peru
Prior art keywords
methyl
compound
ethyl
refers
phenylamine
Prior art date
Application number
PE2000001007A
Other languages
English (en)
Inventor
Murat Acemoglu
Thomas Allmendinger
John Vincent Calienni
David Xu
Olivier Loiseleur
Gottfried Sedelmeier
Jacques Cercus
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20010644A1 publication Critical patent/PE20010644A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/52Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/54Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings
    • C07C211/56Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/15Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE REFIERE A UN PROCESO PARA LA PREPARACION DE ACIDOS 2-FENILAMINO-5-ALQUILFENILACETICOS DE FORMULA I, DONDE R ES METILO Y ETILO; R1 ES Cl, F; R2 ES H, F; R3 ES H, F, Cl, METILO, ETILO, METOXI, ETOXI, OH; R4 ES Cl, F, TRIFLUOROMETILO, METILO; R1, R2, R3, R4 NO SON TODOS F, CUANDO R ES ETILO Y R4 ES H, QUE COMPRENDE HIDROLIZAR UNA LACTAMA DE FORMULA II, CON UNA BASE, SI SE DESEA PROTEGER TEMPORALMENTE LOS GRUPOS REACTIVOS QUE INTERFIERAN, Y LUEGO AISLAR EL COMPUESTO RESULTANTE; CONVERTIR EL ACIDO CARBOXILICO LIBRE DEL COMPUESTO I EN UN DERIVADO DE ESTER. TAMBIEN SE REFIERE A UN PROCESO PARA LA PREPARACION DE UN COMPUESTO II, QUE COMPRENDE OXIDAR UNA LACTAMA DE FORMULA III, O LA CICLACION DEL COMPUESTO VII, ENTRE OTROS. TAMBIEN SE REFIERE A COMPUESTOS OBTENIDOS POR ESTOS PROCEDIMIENTOS COMO ACIDO 5-METIL-2-(2`,4'-DICLORO-6'-METILANILINO)FENILACETICO; ACIDO 5-METIL-2-(2',3',5',6'-TETRAFLLUOROANILINO)FENILACETICO Y A COMPUESTOS INTERMEDIOS. LOS COMPUESTOS I SON INHIBIDORES SELECTIVOS DE CICLOOXIGENASA II
PE2000001007A 1999-09-27 2000-09-25 Procesos para la produccion de acidos 2-fenilamino-5-alquilfenilaceticos PE20010644A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9922830.6A GB9922830D0 (en) 1999-09-27 1999-09-27 Processes

Publications (1)

Publication Number Publication Date
PE20010644A1 true PE20010644A1 (es) 2001-06-15

Family

ID=10861676

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001007A PE20010644A1 (es) 1999-09-27 2000-09-25 Procesos para la produccion de acidos 2-fenilamino-5-alquilfenilaceticos

Country Status (34)

Country Link
US (2) US20080249318A1 (es)
EP (2) EP1216226B1 (es)
JP (1) JP2003510303A (es)
KR (1) KR100745341B1 (es)
CN (1) CN100412053C (es)
AR (2) AR031529A1 (es)
AT (1) ATE447547T1 (es)
AU (1) AU775416B2 (es)
BR (1) BR0014314A (es)
CA (1) CA2379553C (es)
CO (1) CO5210865A1 (es)
CY (1) CY1110539T1 (es)
CZ (1) CZ20021027A3 (es)
DE (1) DE60043261D1 (es)
DK (1) DK1216226T3 (es)
EC (2) ECSP003680A (es)
ES (1) ES2338209T3 (es)
GB (1) GB9922830D0 (es)
HK (1) HK1047739A1 (es)
HU (1) HUP0202728A3 (es)
IL (2) IL148330A0 (es)
MY (1) MY125201A (es)
NO (1) NO327912B1 (es)
NZ (1) NZ517461A (es)
PE (1) PE20010644A1 (es)
PL (1) PL207777B1 (es)
PT (1) PT1216226E (es)
RU (1) RU2273628C2 (es)
SI (1) SI1216226T1 (es)
SK (1) SK287241B6 (es)
TR (1) TR200200745T2 (es)
TW (1) TWI270540B (es)
WO (1) WO2001023346A2 (es)
ZA (1) ZA200202367B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209257D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
GB0224198D0 (en) * 2002-10-17 2002-11-27 Novartis Ag Organic compounds
PE20040844A1 (es) 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
US7161026B1 (en) 2005-07-08 2007-01-09 Property Development Corporation International, Ltd, Inc. Method of preparation of methyl-benzyl-ketone
AR061623A1 (es) 2006-06-26 2008-09-10 Novartis Ag Derivados de acido fenilacetico
WO2010056741A2 (en) 2008-11-12 2010-05-20 Auspex Pharmaceuticals, Inc. Phenylacetic acid inhibitors of cyclooxygenase
CN102311355B (zh) * 2011-09-26 2014-02-05 扬州天和药业有限公司 罗本考昔的一种制备方法
CN107721901A (zh) * 2017-11-12 2018-02-23 刘磊 一种2‑[2‑(2,3,5,6‑四氟苯胺基)苯基]乙酸的制备方法
EP3830072A1 (en) 2018-07-27 2021-06-09 KRKA, d.d., Novo mesto A process for the preparation of polymorphic form of robenacoxib
KR20210041579A (ko) * 2018-08-03 2021-04-15 닛산 가가쿠 가부시키가이샤 불화 방향족 제2급 아민 화합물의 제조 방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
IT1097265B (it) 1978-06-23 1985-08-31 Acraf Nouva sintesi di un acido fenilacetico
JPS5677246A (en) * 1980-11-27 1981-06-25 Nissan Chem Ind Ltd Production of substituted phenylacetic acid
DE3404401C2 (de) 1984-02-08 1994-02-10 Hoechst Ag Verwendung von Aryloxy-Verbindungen als Antidots
FR2578836B1 (fr) 1985-03-12 1987-04-17 Rhone Poulenc Spec Chim Procede de chloration selective de composes phenoliques
EP0380712B1 (de) * 1989-01-27 1995-01-04 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten
IT1248032B (it) * 1991-06-11 1995-01-05 Laboratorio Chimico Int Spa Procedimento per la preparazione della n- (2,6-diclorofenil) -n-fenil-n-(cloroacetil)-ammina.
CN1091420A (zh) * 1993-02-25 1994-08-31 永信药品工业股份有限公司 二苯胺衍生物的制备方法
JPH0789951A (ja) * 1993-06-03 1995-04-04 Sterling Winthrop Inc インターロイキン−1β転換酵素阻害剤
US5475139A (en) * 1993-10-22 1995-12-12 Yung Shin Pharm. Ind. Co., Ltd. Method for the preparation of substituted derivatives of diphenyl amine
MX9605196A (es) 1994-04-29 1997-12-31 Sanofi Winthrop Inc Halometilamidas como inhibidores de la proteasa il-1b.
US5576460A (en) * 1994-07-27 1996-11-19 Massachusetts Institute Of Technology Preparation of arylamines
JPH0977664A (ja) * 1995-09-13 1997-03-25 Yakult Honsha Co Ltd シクロオキシゲナーゼ−2特異的阻害剤及び抗炎症剤
US6355680B1 (en) * 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
BR9600975A (pt) * 1996-03-11 1997-12-30 Fundacao Oswaldo Cruz Derivados do ácido gem-difluorfenilacético e de gem-difluorfenilacetamida processo de sua preparação e suas aplicações farmacêuticas
US6034266A (en) * 1996-03-11 2000-03-07 Fundacao Oswaldo Cruz-Fiocruz Gem-difluoro derivative of phenylacetamide and phenylacetic acid and their pharmaceutical uses
CA2208900C (en) 1996-07-18 2006-08-01 Lonza Ag Process for preparing 2-pyrimidinecarboxylates
US5817877A (en) * 1996-09-23 1998-10-06 Yale University Metal-catalyzed amination of organic sulfonates to organic amines
CO4960662A1 (es) 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados

Also Published As

Publication number Publication date
MY125201A (en) 2006-07-31
TR200200745T2 (tr) 2002-06-21
WO2001023346A2 (en) 2001-04-05
ATE447547T1 (de) 2009-11-15
AU775416B2 (en) 2004-07-29
ECSP003680A (es) 2002-04-23
NO20021368D0 (no) 2002-03-19
JP2003510303A (ja) 2003-03-18
KR100745341B1 (ko) 2007-08-02
CA2379553C (en) 2010-09-21
SK287241B6 (sk) 2010-04-07
NO20021368L (no) 2002-05-27
NZ517461A (en) 2003-10-31
AU7906700A (en) 2001-04-30
CA2379553A1 (en) 2001-04-05
NO327912B1 (no) 2009-10-19
HUP0202728A2 (hu) 2002-12-28
EP1216226B1 (en) 2009-11-04
ES2338209T3 (es) 2010-05-05
PL207777B1 (pl) 2011-01-31
WO2001023346A3 (en) 2002-01-10
TWI270540B (en) 2007-01-11
AR042404A2 (es) 2005-06-22
DE60043261D1 (de) 2009-12-17
CY1110539T1 (el) 2015-04-29
SK4142002A3 (en) 2002-08-06
HUP0202728A3 (en) 2003-11-28
IL148330A0 (en) 2002-09-12
US20080249318A1 (en) 2008-10-09
BR0014314A (pt) 2002-11-12
EP2275403A1 (en) 2011-01-19
US20090275758A1 (en) 2009-11-05
RU2273628C2 (ru) 2006-04-10
PL365994A1 (en) 2005-01-24
EP1216226A2 (en) 2002-06-26
GB9922830D0 (en) 1999-11-24
HK1047739A1 (en) 2003-03-07
US7906677B2 (en) 2011-03-15
SI1216226T1 (sl) 2010-03-31
ZA200202367B (en) 2003-02-26
AR031529A1 (es) 2003-09-24
CO5210865A1 (es) 2002-10-30
CN100412053C (zh) 2008-08-20
KR20020030289A (ko) 2002-04-24
CN1377337A (zh) 2002-10-30
IL148330A (en) 2007-02-11
PT1216226E (pt) 2009-12-17
ECSP093680A (es) 2009-02-27
DK1216226T3 (da) 2010-02-01
CZ20021027A3 (cs) 2002-07-17

Similar Documents

Publication Publication Date Title
PE20010644A1 (es) Procesos para la produccion de acidos 2-fenilamino-5-alquilfenilaceticos
DE3770095D1 (de) Chinazolindione und pyridopyrimidindione.
ATE25665T1 (de) Aethoxycarbonyloxyaethylester von nichtsteroiden entzuendungshemmenden carbonsaeuren, ihre herstellung und anwendung.
EA200100457A1 (ru) Способ получения циталопрама
ES2230719T3 (es) Compuestos basados en azabencimidazol para modular una funcion de proteina-quinasa de serina/treonina.
AR070946A2 (es) Proceso para la preparacion de dihidroxiesteres y derivados de los mismos
CA2356188A1 (en) Method for the preparation of 5-cyanophthalide
AR036331A1 (es) Compuestos utiles como intermediarios en la elaboracion de inhibidores de cetp y procedimiento para obtener dichos intermediarios e inhibidores
EA199900301A2 (ru) Замещенные трициклические соединения
EA200400129A1 (ru) Способ получения периндоприла, его аналогов и солей с использованием 2,5-диоксооксазолидиновых промежуточных соединений
BR0109048A (pt) Processo para a sìntese de citalopram
PE97699A1 (es) Macrolidas cristalinas
ES2159347T3 (es) Naftil-acetamidas como inhibidores de spla2.
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
ATE309992T1 (de) Verfahren zur herstellung von bis-benzazolyl verbindungen
AR248130A1 (es) Procedimiento para la preparacion de 2, 3-piridin-dicarboxilato de dialquilo y derivados de los mismos a partir de una oxima alfa-beta insaturada y un aminobutenodioato.
ATE9225T1 (de) Derivate des 5-hydroxy-tetrahydro-2-furanons.
AR014738A1 (es) Nuevo procedimiento de preparacion de la fexofenadina y compuestos intermediarios
TR200002959A2 (tr) Pirazolo [4,3-D] pirimidin -7-onlar-3-piridilsülfonun bileşikleri ve bunların ara-bağlarının preparasyon işlemi
FI921057A0 (fi) Process foer framstaellningen av peroxykarboxylsyror med anvaendning av en enzymkatalysator.
ATE56697T1 (de) Polymerisierbare verbindungen und verfahren zu ihrer herstellung.
DE602004017855D1 (de) Wendung von druck
ATE1175T1 (de) Verfahren zur herstellung optisch aktiver alpha-cyanalkohole.
ATE325101T1 (de) Hexahydroindenopyridinverbindungen mit antispermatogener aktivität
ES2155350B1 (es) Procedimiento de preparacion de un antibiotico de cefalosporina oralmente activo, cefixime.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed